ST. LOUIS, MISSOURI – Avadel Pharmaceuticals, a dynamic biopharmaceutical company driven by a mission to transform medicines and improve lives, has selected The Christopher Group to lead their Head of Talent & Organizational Development search. Managing Partner, Tobin Anselmi and Recruiting Director, Kristen Perez are leading the key HR search.
“Kristen and I are thrilled to partner with Avadel on this pivotal search. This role offers an incredible opportunity for a dynamic talent professional to drive real change and shape the future of the organization’s human capital. The potential for making a lasting impact here is truly inspiring,” shared Tobin, Managing Partner at The Christopher Group.
In this newly created role, the Head of Talent & Organizational Development will develop and execute a comprehensive talent management, organizational development and talent acquisition strategy aligning with Avadel’s core values and preparing them to scale. This role has a unique opportunity to put a thumbprint on a small but growing organization through the strategic direction, management, optimization, execution, and oversight of all Talent initiatives. Â
To learn more about this opportunity and/or The Christopher Group please contact Kristen Perez at kristen.perez@tcgco.com.
About Avadel Pharmaceuticals
Avadel Pharmaceuticals is a dynamic biopharmaceutical company driven by a mission to transform medicines and improve lives. They focus on innovative solutions that tackle the challenges patients face with current treatment options. One of the company’s key advancements is in the area of oxybate therapy, which is a widely used treatment for excessive daytime sleepiness (EDS) and cataplexy in individuals with narcolepsy. While traditional oxybate products require two nightly doses—one at bedtime and another in the middle of the night—Avadel has revolutionized this with their new therapy, LUMRYZ.Â
LUMRYZ, which received FDA approval on May 1, 2023, offers a once-nightly dose that eliminates the need for patients to wake up during the night for a second dose. This major improvement has earned LUMRYZ seven years of Orphan Drug Exclusivity from the FDA, and it is recognized as clinically superior to the previously available therapies.Â
What sets Avadel apart is its dedication to making a positive impact—not just for patients but also for their community and one another. Employees live the Avadel Values in everything they do, which is what makes working at Avadel a special experience. Â
About The Christopher Group
Through its award-winning, customized HR solutions, The Christopher Group (TCG) delivers critical human capital solutions in the area of executive HR search, interim HR leaders, fractional CHROs, and HR advisory and consulting. Since 1998, TCG has served clients across all industries, locations, company sizes, and verticals. Staffed by former HR professionals and highly trained search practitioners who have sat in the job, TCG has been named one of the Fastest-Growing, Best Non-Profit, Diversity, Private Equity, and Top 50 Executive Recruiting Firms by Hunt Scanlon as well as Forbes’ 2019, 2020, 2021 & 2022 list of America’s Best Executive Recruiting Firms.